Introduction:Basic information about CAS 112246-15-8|20(R)-Ginsenoside Rh2, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 20(R)-Ginsenoside Rh2 |
|---|
| CAS Number | 112246-15-8 | Molecular Weight | 622.873 |
|---|
| Density | 1.19 | Boiling Point | 726.4±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C36H62O8 | Melting Point | 225 °C |
|---|
| MSDS | / | Flash Point | 393.1±32.9 °C |
|---|
Names
| Name | ginsenoside Rh2 |
|---|
| Synonym | More Synonyms |
|---|
20(R)-Ginsenoside Rh2 BiologicalActivity
| Description | 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. |
|---|
| Related Catalog | Signaling Pathways >>Apoptosis >>ApoptosisResearch Areas >>CancerResearch Areas >>Inflammation/ImmunologySignaling Pathways >>Metabolic Enzyme/Protease >>MMP |
|---|
| References | [1]. Choi WY, et al. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. [2]. Chung KS, et al. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression. Carcinogenesis. 2013 Feb;34(2):331-40. [3]. Choi S, et al. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases. Pharm Res. 2009 Oct;26(10):2280-8. |
|---|
Chemical & Physical Properties
| Density | 1.19 |
|---|
| Boiling Point | 726.4±60.0 °C at 760 mmHg |
|---|
| Melting Point | 225 °C |
|---|
| Molecular Formula | C36H62O8 |
|---|
| Molecular Weight | 622.873 |
|---|
| Flash Point | 393.1±32.9 °C |
|---|
| Exact Mass | 622.444458 |
|---|
| PSA | 139.84000 |
|---|
| LogP | 5.62 |
|---|
| Vapour Pressure | 0.0±5.4 mmHg at 25°C |
|---|
| Index of Refraction | 1.572 |
|---|
| InChIKey | CKUVNOCSBYYHIS-FJSBSAJOSA-N |
|---|
| SMILES | CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C |
|---|
Synonyms
| (3β,12β,20R)-12,20-Dihydroxydammar-24-en-3-yl β-D-glucopyranoside |
| 20(R)-Ginsenoside Rh2 |
| 20(R)-Ginsenoside-Rh2 |
| b-D-Glucopyranoside, (3b,12b,20R)-12,20-dihydroxydammar-24-en-3-yl |
| Ginsenoside-Rh2 |
| (R) Ginsenoside Rh2 |
| (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-d-glucopyranoside |
| 20-(R)-Ginsenoside Rh2 |
| β-D-Glucopyranoside, (3β,12β,20R)-12,20-dihydroxydammar-24-en-3-yl |
| 20(R)-GINSENOSIDERH2 |
| Ginsenoside Rh2, 20(R)- |